Meditation: what Cochrane and the major trials actually show

What “meditation” actually covers

In trial evidence, meditation is shorthand for several distinct practices, each with its own evidence base:

• Mindfulness-Based Stress Reduction (MBSR). Eight-week structured programme. The most-studied secular form. Combines body scan, sitting meditation, gentle yoga, and daily home practice.
• Mindfulness-Based Cognitive Therapy (MBCT). Eight-week structured programme that integrates MBSR with cognitive-therapy elements. Specifically developed for relapse prevention in recurrent depression. AU-recognised maintenance intervention.
• Transcendental Meditation (TM). Mantra-based practice, 20 minutes twice daily. Smaller but reasonable evidence base for blood pressure specifically.
• Loving-kindness / compassion meditation. Smaller evidence base for empathy, mood, and social connection outcomes.
• App-based / self-guided meditation. Calm, Headspace, Smiling Mind (Australian-developed). Smaller, less reproducible trial signals than structured programmes. Useful as entry-level access.

The trial evidence varies substantially across these categories. Generic claims about “meditation” usually rest on MBSR or MBCT data; app-based outcomes are weaker.

A. Core clinical — what the trial evidence shows

Blood pressure. The American Heart Association 2013 scientific statement — and several subsequent meta-analyses — put the average systolic blood-pressure reduction from regular meditation practice at approximately 4–5 mmHg. Comparable to weight loss of 3–4 kg; less than a typical first-line antihypertensive. Real but modest. The Heart Foundation 2023 cardiovascular guideline includes mind-body interventions in the lifestyle-first recommendations.

Anxiety and depression. The Goyal JAMA Internal Medicine 2014 meta-analysis of 47 trials and 3,515 participants found moderate-strength evidence for mindfulness meditation programmes in reducing anxiety, depression, and stress symptoms. Effect sizes were modest (Hedges’ g around 0.3–0.4 for these outcomes at 8 weeks). Not a substitute for evidence-led psychological therapy or medication in moderate-to-severe illness; useful as adjunct or first-line in mild-to-moderate presentations.

Recurrent depression maintenance. The Kuyken Lancet 2015 trial compared MBCT to maintenance antidepressant therapy in 424 adults with recurrent depression. The two approaches were broadly equivalent for preventing relapse over 2 years. The RANZCP Mood Disorders guideline recognises MBCT as an option for relapse prevention in recurrent depression.

Chronic pain. Modest effect sizes — about 0.3 standard deviations reduction in pain-intensity scales in pooled trials. Most useful as part of a multimodal pain-management programme (physical therapy + structured psychological + paced activity + appropriate pharmacotherapy where indicated).

Sleep. Modest improvements in sleep-onset latency and sleep quality, larger when meditation is delivered as part of a structured CBT-for-insomnia (CBT-I) programme.

Cardiovascular events. Long-term trials of meditation on hard cardiovascular endpoints are limited. The mechanistic plausibility (BP reduction, stress-axis modulation) is reasonable; the direct evidence is suggestive rather than definitive.

B. Evidence appraisal — what doesn’t hold up

Broad disease-curing claims. The trial evidence is consistent with adjunct benefit, not curative effect. Claims that meditation resolves cancer, autoimmune disease, or chronic infection do not reflect AU primary-tier evidence.

Vague spiritual claims. Some marketed meditation programmes promise transformation, spiritual awakening, or “consciousness expansion” — those claims are outside the scope of clinical evidence. People are free to pursue them; they’re not what’s being measured in clinical trials.

Meditation as replacement for therapy in moderate-to-severe mental illness. Not supported. RANZCP, Beyond Blue, and Black Dog Institute all position meditation as adjunct, not substitute, in clinically significant depression, anxiety, PTSD, or bipolar disorder.

Intensive retreats. Multi-day silent retreats have some reported adverse-event signals — transient depersonalisation, anxiety, sleep disturbance — that are not present at the same rate in 8-week community programmes. People with active mental-health concerns should discuss with a treating clinician before intensive retreat attendance.

Trauma-informed considerations. Standard mindfulness practice involves attention to internal experience, which can be activating for people with significant trauma history. Trauma-informed mindfulness protocols exist and are appropriate where indicated; standard MBSR is not always the right starting point post-trauma.

C. Australian operations — how this fits into general practice

The AU pathway:

• Long consultation (MBS items 36 or 44) — discuss meditation as part of a stress-management or chronic-disease conversation. Brief screen for any contraindication (active trauma, severe mental illness, history of dissociative episodes).
• Mental Health Treatment Plan (item 2715 or 2717) — 10 subsidised psychology sessions per calendar year. Many accredited practising psychologists deliver MBSR or MBCT under this pathway.
• GP Management Plan (item 721) + Team Care Arrangement (item 723) — for chronic-condition comorbidity, accesses 5 subsidised allied-health visits/year.
• Community programmes — many AU hospitals, community health centres, and yoga studios run 8-week MBSR. Cost typically AUD $300–600 out of pocket; sometimes covered by workplace EAP or private health funds.
• App-based entry — Smiling Mind (free, AU-developed, evidence-aligned) is a reasonable low-cost starting point.
• Online structured programmes — This Way Up and MoodGYM offer mindfulness modules within structured CBT.

(MBS / PBS items verified 2026-05-16 via WebSearch — workspace egress to mbsonline.gov.au + pbs.gov.au still blocked; spot-check confirms current.)

D. Practical starting point

For someone in general practice interested in meditation:

Tier	What it looks like
Entry (low commitment)	10 min/day with Smiling Mind for 4 weeks. Free. Tests fit.
Mild–moderate stress, no mental-health red flags	App-based for 4 weeks → community 8-week MBSR if it fits.
Significant stress or recurrent depression	Mental Health Treatment Plan → MBCT or CBT with an accredited psychologist.
Treatment-resistant depression or recurrent severe episodes	Psychiatrist-led plan; MBCT as adjunct, not standalone.
Trauma history	Trauma-informed practitioner; staged approach; don’t start with intensive silent practice.
Acute psychiatric concerns	Standard care pathway first; meditation later as adjunct.

Realistic expectations: the effect size in trials is small-to-moderate. For most people, meditation is a useful adjunct in a multimodal lifestyle + therapy + (where indicated) medication approach to stress, mood, or blood pressure. It is not transformational on its own; it is supportive when stacked with the other foundations.

What this article is and is not

This is general health information drawn from current Australian general practice guidelines, RANZCP, Heart Foundation, Beyond Blue, Black Dog Institute, and peer-reviewed meditation trials. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about therapy, medication, and the right mind-body intervention are made with your own GP and treating clinicians.

For Australian consumer-friendly sources: Smiling Mind, HealthDirect, Better Health Channel, and Beyond Blue.

---

Sources cited

1. RACGP — Red Book
2. Therapeutic Guidelines (eTG)
3. RANZCP — Mood Disorders Clinical Practice Guideline
4. Beyond Blue
5. Black Dog Institute
6. Smiling Mind
7. This Way Up
8. Heart Foundation — CVD guideline 2023
9. Better Access Initiative
10. HealthDirect
11. Goyal M et al. — Meditation programmes for psychological stress (JAMA IM 2014)
12. Kuyken W et al. — MBCT for relapse prevention in depression (Lancet 2015)
13. Brook RD et al. — AHA Scientific Statement on alternative approaches to BP